Abstract: An improved package, suitable for holding a treatment fluid comprising a volatile solvent and kits comprising the package containing the treatment fluid and an applicator are disclosed. The package comprises a reservoir for the liquid which is sealed by a ruturable seal. A cap, coupled to one end of the reservoir, is in the form of a sleeve which is axially translatable along the reservoir from first to second positions. A cutting tool integrated with the cap ruptures the rupturable seal as the cap is moved from first to second positions so that the liquid can thereby be made accessible through an opening in an end wall of the cap. The package provides excellent protection for volatile liquids, yet can be easily opened by a simple press-action, instantly providing access to the liquid so that it can subsequently accessed by a liquid applicator.

Abstract: Corrosion protection agents for treating glassware surfaces, for example dishes and glasses, especially corrosion protection agents comprising zinc-containing materials are provided. Treatment systems and composition of matter, which incorporate these corrosion protection agents, are also provided.

Abstract: The invention relates to a process for making a detergent tablet, comprising the steps of: (a) providing a binder system comprising (i) a binder, and, (ii) optionally, a viscosity modifier, so that the binder system has a shear modulus value G of from 10 to 100 GPa, a phase angle value ? of at least 7°, and a melting point of at least 45° C. at 100 kPa; (b) heating the binder system to above its melting point to form a molten binder system; (c) applying the molten binder system to a base powder comprising a premix of detergent components, to form a detergent composition; and (d) forming the detergent composition into tablets. The present invention is further directed to a tablet composition obtainable by such process and to the use of such a binder system or such a binder, in its molten form for improving the breakage resistance properties of a detergent tablet.

Abstract: The present invention relates to the field of absorbent articles for personal hygiene. Specifically, the present invention provides a superabsorbent material having improved absorbency of complex fluids, such as body fluids like menses. Preferred absorbent articles for personal hygiene in the context of the present invention are feminine care absorbent articles.

Abstract: The invention relates to a process for making a detergent tablet, comprising the steps of: (a) selecting a binder from: sorbitol, xylitol, erythritol, C10-C18 phenol alkoxylates with 20 to 80 equivalents of alkoxylation; C12-C24 alcohol alkoxylates with 50 to 250 equivalents of alkoxylation; castor oil alkoxylates with 50 to 100 equivalents of alkoxylation; mono-, di- and/or tri-esters of glycerin with C12-C25 fatty acids; C10 to C25 fatty acids; and mixtures thereof, (b) heating the binder to above its melting point to form a molten binder; (c) applying the molten binder to a base powder comprising a premix of detergent components, to form a detergent composition; and (d) forming the detergent composition into tablets. The present invention is further directed to a tablet composition obtainable by such process and to the use of such a binder, in its molten form for improving the resistance to breakage of a detergent tablet.

Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.

Abstract: The applicator is used for a placement of an excreta management device on a wearer. The applicator has a longitudinal centerline, a transverse centerline, a device facing surface and an opposing surface. The applicator comprises a handle disposed at transverse ends, a pressure portion disposed along the longitudinal centerline, a middle portion disposed between the handle and the pressure portion and a spacer. When the applicator folded into a pair of right and left pieces along the longitudinal centerline, the spacer is inserted between the right and left pieces. The pressure portion presses the excreta management device toward the wearer's skin during the use of the applicator. The opposing surface of the right piece and the opposing surface of the left piece are separated from one another at the middle portion by the spacer when the applicator is folded.

Abstract: Novel fatty acids and derivatives thereof such as salts, new surfactant systems comprising one or more of these compounds, consumer products such as laundry products, personal care products, pharmaceutical compositions, industrial cleaners, and the like comprising said compounds or surfactant systems.

Abstract: Primary intermediates for hair coloring compositions for oxidative dyeing of hair are compounds of the formula (1): wherein R is selected from C1 to C5 alkyl or hydroxyalkyl, a C3 to C6 cyclic ring containing hetero atoms selected from O, S and N atoms, and —CH2—Ar where Ar is an aromatic ring wherein the aromatic ring may be substituted with one or two hydroxy C1 to C3 alkoxy, or amino groups.

Abstract: Laundry and laundry detergent compositions comprise a fabric enhancement system which comprises one or more polyamines and a transition metal-containing dye protection system which comprises an oligomer formed from the reaction of an imidazole and a crosslinking agent, preferably epichlorohydrin. Said compositions provide fabric integrity benefits but mitigate the coor fidelity problems which may be caused by the use of certain polyamines.

Abstract: The present invention relates to fabric care methods for restoring and/or rejuvenating color of worn, faded fabric, by applying to said fabric a fabric color care composition which comprises: water soluble and/or water dispersible polymers; surfactant capable of forming a bilayer structure; and mixtures thereof. Optionally, the composition can contain other ingredients to provide additionally fabric care benefits, and/or to improve performance and formulatability. The composition is preferably applied as small particle size droplets, especially from spray container which preferably are in association with a set of instructions for use.

Abstract: Primary intermediates for hair coloring compositions for oxidative dyeing of hair are compounds of the formula (1): where R1 and R2 are each individually selected from a hydrogen atom, a C1 to C3 alkyl group, a C1 to C5 mono or dihydroxyalkyl group, phenyl or benzyl optionally substituted with an alkoxy group, or R1 and R2 together with the nitrogen atom to which they are attached form a piperazine, piperidine, imidazole, or morpholine ring.

Abstract: A packaged tooth whitening product is provided. The package includes a substrate having a first side and a second side, wherein the substrate is sized for use in a human user's oral cavity. A first composition including a tooth whitening agent is disposed adjacent the first side of the substrate. A second composition including an aesthetic agent disposed adjacent the second side of the substrate.

Abstract: A simulation press is provided comprising a fixed main body; a carriage associated with the main body for movement relative to the main body; a first plate coupled to the fixed main body and being adapted to engage a workpiece; and a second plate coupled to the carriage for movement with the carriage. The second plate is also adapted to engage the workpiece. One or more motor apparatus are coupled to the fixed main body and the carriage for effecting movement of the carriage relative to the main body. A drive controller is coupled to the motor apparatus for controlling the operation of the motor apparatus in response to feedback from one or more feedback sensors so as to cause the second plate to move relative to the first plate such that the first and second plates engage at least one point site on the workpiece so as to simulate compression loading of a point site on a workpiece in a nip type process.

Abstract: Clear or translucent rinse-added fabric softening compositions are provided via the present invention which have reduced solvent or solvatrope levels. The composition according to the invention comprise: a) a fabric softening active; b) a principal solvent; c) a principal solvent extender; and d) the balance carriers and adjunct ingredients. Preferred embodiments include low perfume level formulations. A preferred class of principal solvent extenders includes hydrophobic oils that aids in fluidizing the system which is characterized by a freezing point of less than 22° C. for in a mixture of the principle solvent extender and 2,2,4-trimethyl-1,3-pentanediol (20%/80% by wt). These principal solvent extenders include materials such as benzyl benzoate, methyl esters derived from canola oil, and mixtures thereof. Alternatively, the preferred principal solvent extenders include cumene sulfonates, xylene sulfonates, toluene sulfonates, C6-C14 sulfonates and sulfates, and mixtures thereof.

Abstract: The present invention relates to a solid particulate fabric-treatment composition comprising: (a) a first perfume component comprising a pro-perfume compound that is the product of a reaction between an amino-functional compound comprising at least one primary and/or secondary amine group and an amine-reactive perfume molecule comprising a ketone and/or an aldehyde functionality; and (b) a second perfume component comprising: (i) at least 30% by weight of the second perfume component of volatile perfume molecules having: (i) a boiling point of less than 250° C.; and (ii) a clogP value of greater than 2; and (iii) an odour detection threshold of less than 50 parts per billion; and (ii) less than 35% by weight of the second perfume component of non-volatile perfume molecules having: (i) a boiling point of greater than 250° C.

Abstract: The present invention relates to methods for treating diseases or disease states which are mediated or otherwise affected by the extracellular release of cytokines, said method comprising the step of administering to a human or higher mammal in need of treatment, one or more of the 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones of the present invention.